Glass Ceiling? – Yes
Challenges? – Ofcourse
Impossible? – NEVER
You experience her quiet power the moment she enters the room;
You see her clarity and vision when she talks about leadership;
You realise her humility and warmth when she notices and appreciates the smallest of things.
She is a an Iconic role model and a trail blazer with many a first to her credit!
KRISIN is super proud and super thrilled to present the #TopPractices of Ms. Kiran Mazumdar-Shaw, Founder, Chairperson & MD of Biocon Ltd.! Ms. Shaw has pioneered many a first, starting decades ago when “glass ceiling” was not yet a term!
Chairperson & Managing Director, Biocon Limited
Ms. Kiran Mazumdar-Shaw is a pioneer of the biotechnology industry in India and the founder of the country’s leading biotechnology enterprise, Biocon. Named among TIME magazine’s 100 most influential people in the world, Ms. Mazumdar-Shaw is recognised as a thought leader who has made her country proud by building a globally recognised bio-pharmaceutical enterprise that is committed to innovation and affordability in delivering best-in-class therapeutics to patients across the globe.
As a global influencer, she is ranked among:
‘World’s 25 Most Influential People in Biopharma’ by Fierce Biotech,
Forbes magazine’s ‘World’s 100 Most Powerful Women’ and
Fortune’s ‘Top 25 Most Powerful Women in Asia-Pacific.’
She has been recognised as the only Indian on Forbes’ list of ‘World’s Self-Made Women Billionaires.’
She has been featured in ‘The Worldview 100 List’ of the most influential visionaries by Scientific American magazine and named among the ‘100 Leading Global Thinkers’ by Foreign Policy magazine.
She has been ranked No. 1 in the Business Captains category on ‘Medicine Maker Power List’ 2018, an index of the 100 most influential people across the globe in the field of medicine, where she has been among the Top 10, consecutively since 2015.
She was felicitated with ‘Advancing Women in Science and Medicine (AWSM) Award for Excellence’ 2017 by The Feinstein Institute for Medical Research, USA. She was honoured with the prestigious ‘Women Leader of the Decade Award’ at the India Pharma Awards 2017 organised during CPhI & PMEC India, South Asia’s largest pharmaceutical event.
She has been named ‘India’s Most Respected Entrepreneur’ for 2017 by the prestigious Hurun Report and felicitated as an exceptional woman achiever by Ministry of Women and Child Development, Govt. of India for being the first Indian business woman to reach USD 1 billion net-worth.
In 2016, she was conferred with the highest French distinction – Chevalier de l’Ordre National de la Légion d’Honneur (Knight of the Legion of Honour). She was also bestowed with ‘The Global Leadership in Engineering Award’ by Los Angeles-based USC Viterbi, School of Engineering in 2016 for excellence in biotechnology worldwide.
The U.S.-based Chemical Heritage Foundation has conferred her with the ‘2014 Othmer Gold Medal’ and the Germany-based Kiel Institute for the World Economy has awarded her its coveted ‘2014 Global Economy Prize’ for Business.
She has received two of India’s highest civilian honours, the Padma Shri (1989) and the Padma Bhushan (2005).
Ms Mazumdar-Shaw holds key positions in various industry, educational, government and professional bodies. She has been appointed as a member of the high-level expert committee constituted by the Department of Biotechnology (DBT) to review the autonomous organisations under the administrative control of the department and more recently as a Governing Council Member of the National Institute of Immunology, an autonomous research institute of the DBT.
She has been appointed as Member of the Steering Committee of the National Biopharma Mission, an industry-academia collaborative mission of the DBT. She is Non-Executive Chairperson of the Association of Biotechnology Led Enterprises (ABLE), a not-for-profit pan-India forum representing the Indian biotechnology sector.
She is a founder member of Karnataka’s Vision Group on Biotechnology, which she currently chairs. She has also been appointed Chairperson of the Karnataka government’s Vision Group to encourage pharma and medical devices units in the state.
She serves as a member of the Governing Body of the Indian Pharmacopoeia Commission and has previously served as a member of the Board of Trustees of the US Pharmacopeia Convention. She is on the board of directors of the US-India Business Council (USIBC) and the Advisory Council of the UK-India Business Council.
She has been appointed as Global Alumni Ambassador for Australia by the Department of Foreign Affairs and Trade, Australia and recently she has been appointed as the Victorian Business Ambassador by The State Govt. of Victoria, Australia. She is also the Honorary Consul of Ireland in Bangalore.
Ms Mazumdar-Shaw has been elected as a full-term member of the Board of Trustees of The MIT Corporation, USA, and is on the board of advisors for The National Society of High School Scholars, USA. She is on the board of trustees of the Keck Graduate Institute in U.S.
She is a Member of the Board of Governors of Indian Institute of Technology Bombay, founder member of the Society for the Institute for Stem Cell Biology and Regenerative Medicine, Bangalore and is the past Chairperson of the Board of Governors of the Indian Institute of Management, Bangalore. She also serves as the Lead Independent Member of the Board of Infosys Ltd and Non-Executive Director on the Board of Narayana Health.
Ms. Mazumdar-Shaw is involved in several charitable organisations. She serves on the Global Advisory Committee for the Women and the Green Economy Campaign (WAGE)™ initiative and is a member of the MIT Charter Society, USA, in honour of her philanthropic commitment to the Institute. She is also associated with The Live Love Laugh Foundation, a leading not-for-profit organisation spreading mental health awareness, as a member of its Board of Trustees.
Ms Mazumdar-Shaw’s commitment to affordable healthcare extends beyond business. Her philanthropic initiatives are directed at making a difference to the lives of the marginalised communities. Through Biocon Foundation’s primary healthcare centres, telemedicine initiatives, health awareness programs, public health and sanitation initiatives and preventive screenings for oral and cervical cancer, she is making an enduring impact on society.
She has also established the 1,400-bed Mazumdar-Shaw Medical Centre in Bangalore to deliver affordable world-class cancer care services to patients irrespective of socio-economic status. She has also set up the Mazumdar -Shaw Centre for Translational Research, a non-profit research institute dedicated to developing scientific breakthroughs for treating a wide range of human diseases.
Her philanthropic efforts have led her to be featured in the Forbes’ List of ‘Heroes of Philanthropy’. Ms. Mazumdar-Shaw is also the second Indian to join the Giving Pledge global initiative created by Warren Buffett and Bill and Melinda Gates that encourages billionaires to give the majority of their wealth to philanthropic causes.
Ms Mazumdar-Shaw holds a bachelor’s degree in science (Zoology Hons.) from Bangalore University and has earned a master’s degree in malting and brewing from Ballarat College, Melbourne University.
She has been awarded with several honorary degrees from Ballarat (2004), University of Abertay (2007), University of Glasgow (2008), Heriot-Watt University (2008), National University of Ireland (2012) and Trinity College, Dublin (2012) for her pre-eminent contributions in the field of biotechnology.
Ms Mazumdar-Shaw is married to Mr. John Shaw, a Scotsman and Indophile, who headed a leading textiles MNC Madura Coats from 1991-1998 as Chairman and Managing Director. Mr. John Shaw is currently the Vice-Chairman and Non-Executive Director of Biocon.
Youtube and Blog pages of her interviews :
Few Interesting Links:
Business Standard 01 Aug 2018 Biocon Targets $200mn Revenue fom Biosimilars
MINT 16 Jul 2018 A collector’s Passion for Art and Science…
The Hindu 27 July 2018 Biologics, Research boost Biocon Profit
Business Standard 01 May 2018 Biocon bets big on Biosimilar
Times of India 06 Jun 2018 Biocon to manufacture Fulphila in Bengaluru facility, says CMD
The Economic Times 05 Dec 2017 US FDA Nod for Cancer Biosimilar is a Big Triumph
The Ken 04 Dec 2017 Behind Biocon’s Payday